Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangcheng Zhang

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncogenesis|September 26, 2018
Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancerXiaohong Xia, Yuning Liao, Zhiqiang Guo, et al.
Frontiers in Pharmacology|February 15, 2021
<i>Allium macrostemon</i> Saponin Inhibits Activation of Platelet via the CD40 Signaling PathwaySisi Ling, Lijun Jin, Shizheng Li, et al.
European Journal of Pharmacology|January 15, 2019
Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signalingNingning Liu, Zhiqiang Guo, Xiaohong Xia, et al.
Frontiers in Molecular Biosciences|May 12, 2020
Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa BFangcheng Zhang, Ruqin Xu, Renjie Chai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2024
RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney DiseaseHongtu Hu, Jijia Hu, Zhaowei Chen, et al.
Cancer|June 24, 2026
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O<sup>6</sup>-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 studyBian Wu, Zhanjie Zhang, Hui Ma, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncogenesis|September 26, 2018
Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancerXiaohong Xia, Yuning Liao, Zhiqiang Guo, et al.
Frontiers in Pharmacology|February 15, 2021
<i>Allium macrostemon</i> Saponin Inhibits Activation of Platelet via the CD40 Signaling PathwaySisi Ling, Lijun Jin, Shizheng Li, et al.
European Journal of Pharmacology|January 15, 2019
Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signalingNingning Liu, Zhiqiang Guo, Xiaohong Xia, et al.
Frontiers in Molecular Biosciences|May 12, 2020
Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa BFangcheng Zhang, Ruqin Xu, Renjie Chai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2024
RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney DiseaseHongtu Hu, Jijia Hu, Zhaowei Chen, et al.
Cancer|June 24, 2026
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O<sup>6</sup>-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 studyBian Wu, Zhanjie Zhang, Hui Ma, et al.
Pageof 4